General
Preferred name
methylprednisolone acetate
Synonyms
6alpha-METHYLPREDNISOLONE ACETATE ()
NSC-19987 acetate, Medrol acetate ()
Depmedalone ()
NSC-48985 ()
Medrol Acetate ()
Neo-Medrone ()
Methylprednisolone 21-acetate ()
Medrol ()
Depo-Medrol ()
M-predrol ()
Methyl prednisolone acetate ()
Depo-Medrone ()
6?-Methylprednisolone 21-acetate ()
P&D ID
PD003030
CAS
53-36-1
Tags
natural product
drug
available
Approved by
FDA
First approval
1959
Drug Status
approved
vet_approved
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
NPC Screening Collection
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
30
Properties
(calculated by RDKit )
Molecular Weight
416.22
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
4
Aromatic Ring Count
0
cLogP
2.37
TPSA
100.9
Fraction CSP3
0.71
Chiral centers
8.0
Largest ring
6.0
QED
0.69
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Immunology/Inflammation
Vitamin D Related/Nuclear Receptor
Target
Glucocorticoid Receptor
ACE,Apoptosis related,Autophagy,Glucocorticoid Receptor,Immunology & Inflammation related,Interleukins
Source data
